Aquinox to stop development of bladder pain drug; shares slump

(Reuters) - Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its lead drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, sending its shares down 12.1 percent before the bell.